Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 1/20 | 0.34 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | ANPEP | P15144 | 1/20 | 0.31 |
| ▸ | LAP3 | P28838 | 1/20 | 0.31 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.30 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.30 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18505873 | 0.76 | LPL (0.38) | LPLLIPGMMP2MMP9ANPEP | |
| SCHEMBL12327478 | 0.72 | APLNR (0.36) | ANPEPLAP3 | |
| SCHEMBL18496989 | 0.68 | LPL (0.42) | LPLLIPGMMP2MMP9ANPEP | |
| SCHEMBL4622011 | 0.68 | ALDH1A1 (0.39) | LPLLIPGMMP2MMP9CYP1A2 | |
| SCHEMBL12327929 | 0.67 | MMP2 (0.39) | LPLLIPGMMP2MMP9ANPEP | |
| SCHEMBL11432661 | 0.65 | ALDH1A1 (0.41) | MMP2MMP9CYP1A2HCAR3HCAR2 | |
| SCHEMBL12295812 | 0.63 | ANPEP (0.37) | LPLLIPGMMP2MMP9ANPEP | |
| SCHEMBL19809221 | 0.60 | ALDH1A1 (0.37) | MMP2MMP9CYP1A2HCAR3HCAR2 | |
| SCHEMBL19809331 | 0.59 | ALDH1A1 (0.39) | LPLLIPGMMP2MMP9CYP1A2 | |
| SCHEMBL7863381 | 0.59 | HCAR3 (0.40) | MMP2MMP9SIRT1CYP1A2HCAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180215783-A1 | BIOORTHOGONAL REACTION OF AN AMINE N-OXIDE AND A BORON AGENT | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-08-02 | — | — | US | disclosed |
| US-20180215783-A1 | BIOORTHOGONAL REACTION OF AN AMINE N-OXIDE AND A BORON AGENT | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-08-02 | — | — | US | disclosed |
| WO-2017027337-A1 | BIOORTHOGONAL REACTION OF AN AMINE N-OXIDE AND A BORON AGENT | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-02-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180215783-A1 | BIOORTHOGONAL REACTION OF AN AMINE N-OXIDE AND A BORON AGENT | BBOX1, BLVRB, BTD | LPL 4469/4885LIPG 1549/4885MMP2 1371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.